However, the activation of this pathway causes the binding of PD-L1 expressed on tumor cells to PD-1 on tumor infiltrating lymphocytes, decreasing the immune effect of T cells in the local tumor microenvironment (TME), thereby mediating tumor immune escape and promoting cancer progression (25–27). This evidence concerns the gene PDCD1 and neoplasm.